Valsartan reduced carotid artery wall thickness and decreased plaque thickness in patients with carotid atherosclerosis, according to results from a new report presented at AHA 2013
By Steve Parcell, ND Valsartan is a common blood pressure lowering agent that I like for it beneficail effect aging. Now there is new data on Valsartan and plaque reversal. In the EFFERVESCENT trial researchers hypothesized that the angiotensin receptor blocker valsartan (Diovan, Novartis) would reduce carotid artery wall thickness and inhibit atherosclerotic plaque progression.
